POM: Prescription only medicine
This guidance document has been developed for those physicians initiating and supervising TYSABRI in accordance with the conditions of the Marketing Authorisation of the drug.
For Healthcare Professionals
This form should be read carefully before continuing TYSABRI treatment for more than 2 years.
This form should be read carefully before discontinuing treatment with TYSABRI.
This form should be read carefully before starting treatment with TYSABRI.
Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, UK
0800 008 7401
+44 (0)1628 501 010